Hemophilia Treatment Market by Type (Hemophilia A, Hemophilia B, and Hemophilia C), by Product (Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Antifibrinolytic Agents, and Desmopressin), and by Therapy (Replacement and Gene)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029
- TBI220609
- July 24, 2020
- Global
- 132 pages
- SAC Insights
Abstract
The report covers a forecast and an analysis of the hemophilia treatment market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the hemophilia treatment market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hemophilia treatment market on a global and regional level.
In order to give the users of this report a comprehensive view of the hemophilia treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the hemophilia treatment market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new Type launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the hemophilia treatment market on a global and regional basis.
The study provides a decisive view of the hemophilia treatment market by segmenting it based on type, product, therapy, and region. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Some key players operating in the global hemophilia treatment market are Pfizer, Baxalta, Baxter International, CSL Ltd., Octapharma, Grifols, Novo Nordisk, Kedrion, Bayer, Biogen Idec, and Hospira.
This report segments the global hemophilia treatment market into:
Global Hemophilia Treatment Market: By Type
Hemophilia A
Hemophilia B
Hemophilia C
Global Hemophilia Treatment Market: By Product
Recombinant Coagulation Factor Concentrates
Plasma Derived Coagulation Factor Concentrates
Antifibrinolytic Agents
Desmopressin
Global Pediatrics Healthcare Market: By Therapy
Replacement Therapy
Gene Therapy
Global Hemophilia Treatment Market: By Region
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Contents
Request Table Of Content
Click To Request Sample
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Hemophilia Treatment Market Revenue, 2016-2025 (USD Million)
2.2. Global Hemophilia Treatment Market: Snapshot
C
| read more...
Related Reports
Global Hemostasis Cannulas Sales Data & Market Report 2020 and Forecast 2021-2026
Published : 21, January
Published : 21, January